EW Q3 2017 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$822M+11.1% YoY

Gross Profit

$605M73.7% margin

Operating Income

$218M26.5% margin

Net Income

$170M20.7% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$311M

Free Cash Flow

$268M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$2.3B

Stockholders' Equity

$3.2B

Cash & Equivalents

$630M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$822M	$739M	+11.1%
Gross Profit	$605M	$541M	+11.8%
Operating Income	$218M	$199M	+9.7%
Net Income	$170M	$141M	+20.3%

Revenue Segments

Transcatheter Heart Valves

$481M59%

Surgical Heart Valve Therapy

$196M24%

Critical Care

$145M18%

Geographic Segments

UNITED STATES

$470M57%

Europe

$182M22%

Rest of World

$86M10%

JAPAN

$83M10%